Outset Medical, Inc. Income Statement
OM|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
Outset Medical, Inc. reported $130M in revenue and $173M in net loss for FY2025. Revenue has grown at a 130.4% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $130.4M | $115.4M | $102.6M | $49.9M | $15.1M | $2.0M |
| Cost of Revenue | $101.4M | $97.5M | $95.0M | $63.0M | $32.9M | $8.1M |
| Gross Profit | $29.0M | $17.8M | $7.6M | -$13.0M | -$17.8M | -$6.1M |
| SG&A Expense | $45.2M | $40.5M | $36.3M | $30.5M | $8.9M | $6.3M |
| R&D Expense | $57.3M | $48.9M | $36.7M | $28.9M | $23.3M | $22.9M |
| Operating Income | -$169.8M | -$161.0M | -$130.5M | -$117.5M | -$70.3M | -$46.6M |
| Interest Expense | $12.7M | $3.6M | $1.7M | $2.9M | $4.3M | $4.6M |
| Income Tax | $523.0K | $295.0K | $199.0K | $199.0K | $20.0K | $25.0K |
| Net Income | -$172.8M | -$163.0M | -$131.9M | -$121.5M | -$68.3M | -$49.8M |
| EPS (Basic) | -$52.28 | -$3.38 | -$2.89 | -$4.85 | - | $0.77 |
| EPS (Diluted) | -$52.28 | -$3.38 | -$2.89 | -$4.85 | -$99.58 | $0.74 |
| Shares Outstanding | 3.5M | 50.3M | 48.5M | 47.2M | 42.7M | 922.0K |
| Gross Margin | 22.2% | 15.5% | 7.4% | -26.1% | -118.1% | -304.7% |
| Operating Margin | -130.2% | -139.6% | -127.2% | -235.2% | -466.3% | -2320.0% |
| Profit Margin | -132.5% | -141.2% | -128.6% | -243.3% | -453.0% | -2480.3% |